Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zero2IPO Group is a leading integrated service provider for the equity investment industry in China, specializing in data, marketing, investment banking, and asset management services. Founded in 1999, the company operates the PEdata platform, which is one of the most comprehensive databases for venture capital and private equity activity in the Greater China region. While not a biotechnology or pharmaceutical developer, Zero2IPO is a pivotal player in the healthcare ecosystem, providing critical market intelligence and capital-raising support for life science startups. The group is well-known for its influential industry rankings and research reports that track investment trends across various sectors, including healthcare and deep tech. Zero2IPO Holdings Inc. is publicly listed on the Hong Kong Stock Exchange under the stock code 1945.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zero2IPO Group.